“We are incredibly honoured that CandorVision has received this nomination” – Dr. Frank Heidemann, Founder and CEO, CandorVision.
On October 5th, McKesson Canada hosted their Annual Distinction Awards Gala, which recognizes companies that provide excellence in manufacturing and collaboration toward improving the health for millions of Canadians.
CandorVision has been identified by McKesson Canada as a finalist for the prestigious D.W. Bole award, one of the seven Distinction Awards presented to a manufacturer going above and beyond in their category.
The D.W. Bole Award highlights distinction in growth, service, operational excellence, and business policy. CandorVision is honoured to have merited this award, as we focus on improving the eye health of Canadian patients with “Gold Standard” treatments and service.
“We are incredibly honoured that CandorVision has received this nomination. We are truly happy that our growing collaboration with McKesson has broadened our ability to provide high-quality treatments to dry eye patients and pharmacies across Canada. We are motivated to continue demonstrating outstanding service and excellence in our ongoing determination toward improvement,” said Dr. Frank Heidemann, Founder and CEO, CandorVision.
CandorVision is a Canadian-owned and operated company focusing on improving the level of eye healthcare through innovation and exceptional service. CandorVision markets and distributes the highest-quality ophthalmic treatments, including the HYLO® family of preservative-free and phosphate-free lubricating eye drops, OCUNOX® eye ointment, CALMO® Eye Spray, and soap-free lid hygiene solutions CALMO® Lid Care and NACLINO™ Lid Wipes.
McKesson is a Fortune 500 company, established as the number one pharmaceutical distributor in the world. The company is dedicated to improving the business of healthcare by partnering with healthcare teams across multiple disciplines. By helping its partners improve their financial, operational, and clinical performance across all disciplines, McKesson aims to build healthier organizations to enhance patient care.